Pharmacokinetics of Tocolytic Agents

作者: Vassilis Tsatsaris , Dominique Cabrol , Bruno Carbonne

DOI: 10.2165/00003088-200443130-00001

关键词: TocolyticTocolytic agentStomach emptyingPharmacologyDrug metabolismRoute of administrationChemistryTerbutalineDrugPharmacokinetics

摘要: Tocolytic agents are drugs designed to inhibit contractions of myometrial smooth muscle cells. Such an effect has been demonstrated in vitro or vivo for several pharmacological agents, including β-adrenergic agonists, calcium channel antagonists, oxytocin NSAIDs and magnesium sulfate. However, the aim tocolysis is not only stop uterine prevent preterm delivery, but perinatal morbidity mortality associated with birth. The achievement this goal yet clearly any available, use tocolytic may appear controversial. Therefore, it important avoid maternal fetal toxicity when used. During pregnancy, all steps drug pharmacokinetics altered. Absorption administered orally limited because delayed stomach emptying reduced intestinal motility. volume distribution increased. metabolic activity liver increased, accelerating metabolism lipophilic drugs. Renal filtration leading enhanced renal elimination water-soluble These modifications generally responsible plasma concentration half-life most specific have be taken into account using a pregnant women. review provide reader data about currently used treat labour. women affect choice optimal dosage route administration.

参考文章(97)
Philip J. Lipsitz, THE CLINICAL AND BIOCHEMICAL EFFECTS OF EXCESS MAGNESIUM IN THE NEWBORN Pediatrics. ,vol. 47, pp. 501- 509 ,(1971)
Avroy A. Fanaroff, Richard J. Martin, Neonatal-perinatal medicine: Diseases of the fetus and infant ,(1977)
I. Ingemarsson, M. Westgren, C. Lindberg, B. Ahrén, I. Lundquist, C. Carlsson, Single injection of terbutaline in term labor: Placental transfer and effects on maternal and fetal carbohydrate metabolism American Journal of Obstetrics and Gynecology. ,vol. 139, pp. 697- 701 ,(1981) , 10.1016/0002-9378(81)90489-0
Gunnar Alván, Michael Orme, Leif Bertilsson, Roger Ekstrand, Lena Palmér, Pharmacokinetics of indomethacin Clinical Pharmacology & Therapeutics. ,vol. 18, pp. 364- 373 ,(1975) , 10.1002/CPT1975183364
The Worldwide Atosiban versus Beta-agonists, None, Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour British Journal of Obstetrics and Gynaecology. ,vol. 108, pp. 133- 142 ,(2001) , 10.1111/J.1471-0528.2001.00043.X
T. F. McDonald, S. Pelzer, W. Trautwein, D. J. Pelzer, Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells Physiological Reviews. ,vol. 74, pp. 365- 507 ,(1994) , 10.1152/PHYSREV.1994.74.2.365
A. Forman, P. Gandrup, K.-E. Andersson, U. Ulmsten, Effects of nifedipine on oxytocin- and prostaglandin F2α-induced activity in the postpartum uterus American Journal of Obstetrics and Gynecology. ,vol. 144, pp. 665- 670 ,(1982) , 10.1016/0002-9378(82)90435-5
James E. Ferguson, Donald C. Dyson, Thomas Schutz, David K. Stevenson, A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome American Journal of Obstetrics and Gynecology. ,vol. 163, pp. 105- 111 ,(1990) , 10.1016/S0002-9378(11)90679-6